
ESCMID Study Group for Respiratory viruses – ESGREV
News & Activities
2022 Annual Report Published
The Annual Report showcasing the achievements of the previous year is now available to view. Be sure to check out the report to see what the Study Group was able to accomplish in 2022 as well as what they plan for the future.
ESGREV newsletter published for July 2022
The ESGREV Newsletter for July 2022 has just been published online. Inside you can find a message from the ESGREV Executive Committee and updates on membership, research projects, publications and more. Be sure to read up today!
New ESGREV Executive Committee elected
A new ESGREV Executive Committee has been elected and will now be:
- Chrysanthi Skevaki, Germany
- Roy Chemaly, United States
- Barbara Rath, France
- Sotirios Tsiodras, Greece
- Louis Bont, Netherlands
We thank all previous Executive Committee for their excellent work over the last years. We are looking forward to continuing this work.
You can find the full election report here
2021 Annual Report Published
The Annual Report showcasing the achievements of the previous year is now available to view. Be sure to check out the report to see what the Study Group was able to accomplish in 2021 as well as what they plan for the future.
ESGREV Webinar: Respiratory viral infections in distinct patient populations in the era of the COVID-19 pandemic
Tuesday, 14 December 2021, 14:00 - 17:30 CET
Register for the webinar here (free of charge)
Chairs: Chrysanthi Skevaki, Roy Chemaly
Presentations:
Time (CET) | Title | First Name | Last Name | City, Country |
14.00-14:30 | Respiratory viruses and the elderly patient population | Sotirios | Tsiodras | Athens, Greece |
14:30-15:00 | Are Asthmatic individuals at risk? | Chrysanthi | Skevaki | Marburg & Giessen, Germany |
15:00-15:30 | Respiratory viruses in patients with COPD | Sebastian | Johnston | London, UK |
15:30-16:00 | Impact of COVID-19 on circulating respiratory viruses in immunocompromised patients | Roy | Chemaly | Houston, Texas, US |
16:00-16:30 | Outcomes of respiratory viruses in ICU patients | David | Ong | Rotterdam, Netherlands |
16:30-17:00 | Respiratory viruses and the pulmonary vasculature - Focus on COVID-19 | Natascha | Sommer | Giessen, Germany |
17:00-17:30 | What we learned so far about respiratory viruses including coronaviruses in children? | Barbara | Rath | Besancon, France and Berlin, Germany |
2020 Annual Report Published
The Annual Report showcasing the achievements of the previous year is now available to view. 2020 was a challenging year due to COVID-19, but check out the report to see what the Study Group was able to accomplish or plan for the future.
New ESGREV Executive Committee elected
A new ESGREV Executive Committee has been elected and will now be:
- Chrysanthi Skevaki, Germany
- Roy Chemaly, United States
- Barbara Rath, France
- Sotirios Tsiodras, Greece
- David Ong, Netherlands
We thank all previous Executive Committee for their excellent work over the last years. We are looking forward to continuing this work.
You can find the full election report here
Survey on Point of Care testing (POCT)
May 9, 2019
The Executive Committee of ESCMID Study Group for Respiratory Viruses would like to invite ESCMID members to respond to the “Survey on Point of Care testing (POCT) for seasonal influenza and other respiratory viruses”. This survey aims to capture the current status of use of point of care testing in the ESCMID community and to highlight areas of best practice and areas where further work is required. Please fill in the survey by following this link:
https://www.surveymonkey.co.uk/r/ESGREVsurvey
Please feel free to share this survey with your colleagues; that would substantially help collect solid data from Europe and beyond.